Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
暂无分享,去创建一个
Y. Doki | M. Mori | I. Takemasa | T. Mizushima | Hirofumi Yamamoto | J. Nishimura | N. Haraguchi | M. Uemura | Masahisa Ohtsuka | Ryota Oshiro
[1] Y. Doki,et al. C4.4A is associated with tumor budding and epithelial–mesenchymal transition of colorectal cancer , 2012, Cancer science.
[2] K. Mimori,et al. Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer , 2010, Cancer science.
[3] B. Nielsen,et al. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma , 2008, International journal of cancer.
[4] B. Skov,et al. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. , 2007, Lung cancer.
[5] R. Hautmann,et al. C4.4A as a candidate marker in the diagnosis of colorectal cancer , 2007, British Journal of Cancer.
[6] Ole N Jensen,et al. Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. , 2004, The Biochemical journal.
[7] M. Monden,et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. , 2003, Gastroenterology.
[8] M. Schenker,et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan , 2003, British Journal of Cancer.
[9] M. Monden,et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Ueno,et al. Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.
[11] J. Southgate,et al. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. , 2001, Cancer research.
[12] U. Reinhold,et al. Upregulation of C4.4A expression during progression of melanoma. , 2001, The Journal of investigative dermatology.
[13] M. Schwab,et al. Cloning of the human homologue of the metastasis-associated rat C4.4A. , 2001, Gene.
[14] M Monden,et al. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. , 2000, Cancer research.
[15] I. Schieren,et al. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells , 1999, Oncogene.
[16] M. Zöller,et al. Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor , 1998, Oncogene.
[17] M. Zöller,et al. Developmentally regulated expression of metastasis-associated antigens in the rat. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[18] K. Hase,et al. Prognostic value of tumor “budding” in patients with colorectal cancer , 1993, Diseases of the colon and rectum.
[19] M. Zöller,et al. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. , 1989, Cancer research.